Nonsustained ventricular tachycardia in severe heart failure: Independent marker of increased mortality due to sudden death

Circulation

Volumn 94, Issue 12, 1996, Pages 3198-3203

  Doval, Hernan C ^a   Nul, Daniel R ^b   Grancelli, Hugo O ^b   Varini, Sergio D ^b   Soifer, Saul ^b   Corrado, Gianni ^b   Dubner, Sergio ^b   Scapin, Omar ^b   Perrone, Sergio V ^b  

^a NONE   (Argentina)

^b NONE

Author keywords

arrhythmias; death, sudden; heart failure

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; NITRITE; RADIOISOTOPE; SODIUM;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SODIUM RESTRICTION; SUDDEN DEATH; THORAX RADIOGRAPHY;

EID: 0030454152     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3198     Document Type: Article

References (24)

1. Franciosa J, Wilen M, Ziesche S, Cohn J. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983;51:831-836.
2. Maskin C, Siskind S, Le Jemtel T. High incidence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart J. 1984;107:896-901.
3. Dargie H, Cleland J, Leckie B, Inglis C, East B, Ford I. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation. 1987;75(suppl IV):IV-98. Abstract.
4. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS), N Engl J Med. 1987;316:1429-1435.
5. Wilson J, Schwartz S, St John Sutton M, Ferraro N, Horowitz L, Reichek N, Josephson M. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol. 1983;2:403-410.
6. Chakko C, Gheorghiade M. Ventricular arrhythmia in severe heart failure: incidence, significance and effectiveness of antiarrhythmic therapy. Am Heart J. 1985;109:497-504.
7. Bayes de Luna A, Coumel P, Leclerk J. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151-159.
8. Nickolic G, Bishop R, Singh J. Sudden death recorded during Holter monitoring. Circulation. 1982;66:218-225.
9. Francis G. Development of arrhythmia in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. Am J Cardiol. 1986;57(suppl):3B-7B.
10. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S, for the Captopril-Digoxin Study Group. Prediction of total morbidity and sudden death in mild to moderate heart failure. J Am Coll Cardiol. 1989;14:564-570.
11. Keogh A, Baron D, Hickie J. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol. 1990;65:903-908.
12. Massie B, Francis G, Tandon P, Anderson S, De Mets D, Packer M, on behalf of the PROMISE Investigators. Asymptomatic ventricular arrhythmias do not identify patients with severe heart failure at risk for sudden death: results of the PROMISE trial. J Am Coll Cardiol. 1993;21:459A. Abstract.
13. Hofman T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, Stienen V, Math D, Treese N, Just H. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J. 1988;116:1455-1463.
14. Doval H, Nul D, Grancelli H, Perrone S, Bortman G, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 1994;1:493-498.
15. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation. 1992; 85(suppl I):I-50-I-56.
16. Bigger T. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation. 1987;75(suppl IV):IV-28-IV-35.
17. Podrid P, Fogel R, Fuchs T. Ventricular arrhythmia in congestive heart failure. Am J Cardiol. 1992;69:82G-96G.
18. Fletcher R, Cintron G, Johnson G, Orndorff J, Carson P, Cohn J, for the V-HeFT II VA Cooperative Studies Group. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. Circulation. 1993;87(suppl VI):VI-49-VI-55.
19. Cohn J, Johnson G, Shabetai R, Loeb H, Tristani F, Rector T, Smith R. Fletcher R, for the V-HeFT VA Cooperative Studies Group. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation. 1993;87(suppl VI): VI-5-VI-16.
20. Ziesche S, Rector T, Cohn J. Interobserver discordance in the classification of mechanism of death in studies of heart failure. J Cardiac Failure. 1995;1:127-132.
21. Luu M, Stevenson W, Stevenson L, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675-1680.
22. Goldstein S, Brooks M, Ledingham R, Kennedy H, Epstein A, Pawitan Y, Bigger J. Association between ease of suppression of ventricular arrhythmia and survival. Circulation. 1995;91:79-83.
23. Pratt C, Moyé L. The Cardiac Arrhythmias Suppression Trial: casting suppression in a different light. Circulation. 1995;91:245-247.
24. The Cardiac Arrhythmias Suppression Trial (CAST) Investigation. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-410.